This announcement is a separate document:
圣湘生物科技股份有限公司关于2023年年度报告信息披露监管问询函的回复公告
Announcement of Sansure Biotech Inc.'s reply to the regulatory inquiry letter regarding the disclosure of information in the 2023 annual report.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.